Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
England’s NICE Says Severity Modifier Working, But Industry Wants Cost Restrictions Lifted
Sep 27 2024
•
By
Eliza Slawther
The ABPI says the cost-neutrality restriction imposed on NICE should be lifted • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Europe
More from Geography